Hongyue Dai
About Hongyue Dai
Hongyue Dai is the VP of Translational Bioinformatics with over two decades of experience in oncology, immuno-oncology, and neural-immune interactions, known for building and leading bioinformatics teams to support drug discovery and development pipelines.
Hongyue Dai VP, Translational Bioinformatics
Hongyue Dai is currently the Vice President of Translational Bioinformatics. With over two decades of experience, Dai focuses on bioinformatics within the fields of oncology, immuno-oncology, and neural-immune interactions. In his role, he builds and leads bioinformatics teams that support drug discovery and development pipelines.
Hongyue Dai Education and Expertise
Dai holds a B.S. in Nuclear Physics from Peking University and earned his Ph.D. from the Institute of High Energy Physics at the Chinese Academy of Science in Beijing, China. His expertise spans bioinformatics, oncology, immuno-oncology, and neural-immune interactions. He has extensive experience in building capabilities to support drug discovery and development.
Cygnal Therapeutics Hongyue Dai
Hongyue Dai served as both Senior Vice President and Vice President of Bioinformatics and Digital Biology at Cygnal Therapeutics. There, he established a robust Bioinformatics team that supported Omics, including single cell RNAseq and image analysis pipelines. He also identified predictive biomarkers and patient populations to advance internal programs.
M2Gen Chief Scientific and Bioinformatics Officer
At M2Gen, Dai held the position of Chief Scientific and Bioinformatics Officer. He developed and executed the molecular strategy for the ORIEN Avatar program, which successfully sequenced 11,000 cancer patients by 2019. His work aimed to transform cancer care through comprehensive molecular profiling.
Merck Informatics Analyst Executive Director
Before his tenure at Cygnal and M2Gen, Dai was an Executive Director and Informatics Analyst at Merck. In this role, he led a global team focused on applying genomic and genetic technologies to impact Merck's pipeline. His leadership contributed to significant advancements in the application of bioinformatics in drug development.
Hongyue Dai High-Energy Astrophysics Career
Earlier in his career, Hongyue Dai distinguished himself in high-energy astrophysics. Notably, he contributed to the discovery of the highest energy cosmic ray ever observed, known as the Oh-My-God particle. This discovery marked a significant milestone in the field of astrophysics.